Vimarsana
Biggest News Aggregation in the World

Page 29 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference - Vimarsana News

Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting - Vimarsana News

DNAtrix Announces Oral Presentation of Positive Overall Survival Data with DNX-2401 in DIPG at the Society for Neuro-oncology (SNO) Annual Meeting

/PRNewswire/ -- DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, today announced that data from the Phase 1 study of DNX-2401 in...

Syndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting - Vimarsana News

Syndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting

/PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies,...

Perceiv AI to present Foresight AD™, a novel prognostic tool to optimize Alzheimer's clinical trials, at the 14th Clinical Trials on Alzheimer's Disease (CTAD 2021) conference - Vimarsana News

Perceiv AI to present Foresight AD™, a novel prognostic tool to optimize Alzheimer's clinical trials, at the 14th Clinical Trials on Alzheimer's Disease (CTAD 2021) conference

/PRNewswire/ - Perceiv Research Inc. (operating as Perceiv AI), a precision medicine company reshaping clinical trials by forecasting disease evolution, today...

Inhibrx Announces Participation in Upcoming Scientific and Investor Conferences - Vimarsana News

Inhibrx Announces Participation in Upcoming Scientific and Investor Conferences

/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...